PMC:7461420 / 17419-17628
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T103 | 31-39 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T200 | 21-29 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptides |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T126 | 21-29 | Chemical | denotes | peptides | http://purl.obolibrary.org/obo/CHEBI_16670 |
| T127 | 31-39 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T128 | 62-71 | Chemical | denotes | molecules | http://purl.obolibrary.org/obo/CHEBI_25367 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T176 | 9-185 | Sentence | denotes | Compared to peptides, proteins, and biologics, small molecules have several advantages due to lower production costs, improved pharmacokinetics, stability, and dosage accuracy. |